Cardiac conditions leading to extracorporeal membrane oxygenation cannulation
| Condition . | Patients (n = 64) . |
|---|---|
| Myocarditis or suspected myocarditis, n (%) | 20 (31.3) |
| Non-myocarditis cardiac disease, n (%) | 44 (68.7) |
| End-stage dilated cardiomyopathy, n (%) | 21 (32.8) |
| Ischaemic cardiomyopathy, n (%) | 8 (12.5) |
| Postcardiotomy shock, n (%) | 4 (6.2) |
| Miscellaneous condition with left ventricular dysfunction, n (%) | 11 (17.2) |
| Rheumatic heart disease, n (%) | 3 (4.7) |
| Repaired congenital heart disease, n (%) | 2 (3.1) |
| Previous orthotopic heart transplantation, n (%) | 6 (9.4) |
| For hypoplastic left heart syndrome | 2 |
| For pulmonary atresia with intact ventricular septum | 1 |
| For restrictive cardiomyopathy | 1 |
| For primitive dilated cardiomyopathy | 1 |
| For peripartum cardiomyopathy | 1 |
| Condition . | Patients (n = 64) . |
|---|---|
| Myocarditis or suspected myocarditis, n (%) | 20 (31.3) |
| Non-myocarditis cardiac disease, n (%) | 44 (68.7) |
| End-stage dilated cardiomyopathy, n (%) | 21 (32.8) |
| Ischaemic cardiomyopathy, n (%) | 8 (12.5) |
| Postcardiotomy shock, n (%) | 4 (6.2) |
| Miscellaneous condition with left ventricular dysfunction, n (%) | 11 (17.2) |
| Rheumatic heart disease, n (%) | 3 (4.7) |
| Repaired congenital heart disease, n (%) | 2 (3.1) |
| Previous orthotopic heart transplantation, n (%) | 6 (9.4) |
| For hypoplastic left heart syndrome | 2 |
| For pulmonary atresia with intact ventricular septum | 1 |
| For restrictive cardiomyopathy | 1 |
| For primitive dilated cardiomyopathy | 1 |
| For peripartum cardiomyopathy | 1 |
Cardiac conditions leading to extracorporeal membrane oxygenation cannulation
| Condition . | Patients (n = 64) . |
|---|---|
| Myocarditis or suspected myocarditis, n (%) | 20 (31.3) |
| Non-myocarditis cardiac disease, n (%) | 44 (68.7) |
| End-stage dilated cardiomyopathy, n (%) | 21 (32.8) |
| Ischaemic cardiomyopathy, n (%) | 8 (12.5) |
| Postcardiotomy shock, n (%) | 4 (6.2) |
| Miscellaneous condition with left ventricular dysfunction, n (%) | 11 (17.2) |
| Rheumatic heart disease, n (%) | 3 (4.7) |
| Repaired congenital heart disease, n (%) | 2 (3.1) |
| Previous orthotopic heart transplantation, n (%) | 6 (9.4) |
| For hypoplastic left heart syndrome | 2 |
| For pulmonary atresia with intact ventricular septum | 1 |
| For restrictive cardiomyopathy | 1 |
| For primitive dilated cardiomyopathy | 1 |
| For peripartum cardiomyopathy | 1 |
| Condition . | Patients (n = 64) . |
|---|---|
| Myocarditis or suspected myocarditis, n (%) | 20 (31.3) |
| Non-myocarditis cardiac disease, n (%) | 44 (68.7) |
| End-stage dilated cardiomyopathy, n (%) | 21 (32.8) |
| Ischaemic cardiomyopathy, n (%) | 8 (12.5) |
| Postcardiotomy shock, n (%) | 4 (6.2) |
| Miscellaneous condition with left ventricular dysfunction, n (%) | 11 (17.2) |
| Rheumatic heart disease, n (%) | 3 (4.7) |
| Repaired congenital heart disease, n (%) | 2 (3.1) |
| Previous orthotopic heart transplantation, n (%) | 6 (9.4) |
| For hypoplastic left heart syndrome | 2 |
| For pulmonary atresia with intact ventricular septum | 1 |
| For restrictive cardiomyopathy | 1 |
| For primitive dilated cardiomyopathy | 1 |
| For peripartum cardiomyopathy | 1 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
